Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Vanhove

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
The Journal of Biological Chemistry|October 28, 1994
Peroxisomal beta-oxidation. Purification of four novel 3-hydroxyacyl-CoA dehydrogenases from rat liver peroxisomesD K Novikov, G F Vanhove, H Carchon, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 10, 2011
A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathyDavid B Clifford, David M Simpson, Stephen Brown, et al.
Antimicrobial Agents and Chemotherapy|November 26, 1997
Pharmacokinetics of saquinavir, zidovudine, and zalcitabine in combination therapyG F Vanhove, H Kastrissios, J M Gries, et al.
Pain|September 21, 2010
Variation in quantitative sensory testing and epidermal nerve fiber density in repeated measurementsMona M Selim, Gwen Wendelschafer-Crabb, James S Hodges, et al.
AIDS Research and Therapy|January 29, 2013
NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trialsStephen Brown, David M Simpson, Graeme Moyle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2007
Pharmacokinetic and safety study of subcutaneously administered weekly ING-1, a human engineere monoclonal antibody targeting human EpCAM, in patients with advanced solid tumorsS Goel, R J Bauer, K Desai, et al.
The Journal of Pain|April 20, 2010
A randomized, controlled, open-label study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteersWilliam R Kennedy, Geertrui F Vanhove, Shiao-Ping Lu, et al.
Pain Practice : the Official Journal of World Institute of Pain|April 28, 2017
Effectiveness and Safety of Intrathecal Ziconotide: Interim Analysis of the Patient Registry of Intrathecal Ziconotide Management (PRIZM)Timothy Deer, Richard L Rauck, Philip Kim, et al.
Pain Medicine (Malden, Mass.)|May 31, 2020
Effectiveness and Safety of Intrathecal Ziconotide: Final Results of the Patient Registry of Intrathecal Ziconotide Management (PRIZM)Gladstone C McDowell, Michael F Saulino, Mark Wallace, et al.
Cellular and Molecular Gastroenterology and Hepatology|May 15, 2022
Robust Colonic Epithelial Regeneration and Amelioration of Colitis via FZD-Specific Activation of Wnt SignalingLiqin Xie, Russell B Fletcher, Diksha Bhatia, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|October 28, 1994
Peroxisomal beta-oxidation. Purification of four novel 3-hydroxyacyl-CoA dehydrogenases from rat liver peroxisomesD K Novikov, G F Vanhove, H Carchon, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 10, 2011
A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathyDavid B Clifford, David M Simpson, Stephen Brown, et al.
Antimicrobial Agents and Chemotherapy|November 26, 1997
Pharmacokinetics of saquinavir, zidovudine, and zalcitabine in combination therapyG F Vanhove, H Kastrissios, J M Gries, et al.
Pain|September 21, 2010
Variation in quantitative sensory testing and epidermal nerve fiber density in repeated measurementsMona M Selim, Gwen Wendelschafer-Crabb, James S Hodges, et al.
AIDS Research and Therapy|January 29, 2013
NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trialsStephen Brown, David M Simpson, Graeme Moyle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2007
Pharmacokinetic and safety study of subcutaneously administered weekly ING-1, a human engineere monoclonal antibody targeting human EpCAM, in patients with advanced solid tumorsS Goel, R J Bauer, K Desai, et al.
The Journal of Pain|April 20, 2010
A randomized, controlled, open-label study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteersWilliam R Kennedy, Geertrui F Vanhove, Shiao-Ping Lu, et al.
Pain Practice : the Official Journal of World Institute of Pain|April 28, 2017
Effectiveness and Safety of Intrathecal Ziconotide: Interim Analysis of the Patient Registry of Intrathecal Ziconotide Management (PRIZM)Timothy Deer, Richard L Rauck, Philip Kim, et al.
Pain Medicine (Malden, Mass.)|May 31, 2020
Effectiveness and Safety of Intrathecal Ziconotide: Final Results of the Patient Registry of Intrathecal Ziconotide Management (PRIZM)Gladstone C McDowell, Michael F Saulino, Mark Wallace, et al.
Cellular and Molecular Gastroenterology and Hepatology|May 15, 2022
Robust Colonic Epithelial Regeneration and Amelioration of Colitis via FZD-Specific Activation of Wnt SignalingLiqin Xie, Russell B Fletcher, Diksha Bhatia, et al.
Pageof 4